U.S. Other Utilities Stock News

NYSEAM:TMP
NYSEAM:TMPBanks

Tompkins Financial (TMP) Stock May Be 5% Overvalued On Current Returns

Tompkins Financial stock has delivered a 79.5% return over the past three years, yet the current checks suggest it no longer looks obviously cheap. The Excess Returns intrinsic value estimate and the market multiples both point to a price that is roughly in line with fair value rather than a clear bargain. Over the last three years Tompkins Financial has returned 79.5%, which puts more pressure on today’s buyers to be confident that fundamentals can justify the higher share price. For a...
NasdaqGS:MANH
NasdaqGS:MANHSoftware

Manhattan Associates Stock And 2 Software Picks For Trade Compliance Demand

Tariff swings and tighter trade rules are turning Foreign Trade Zone operations into a real stress test for corporate systems, and that puts enterprise software providers in the spotlight. Companies are finding that manual workarounds and fragmented tools can mean missed duty savings, audit headaches, and real margin leakage. At the same time, demand is building for integrated ERP and trade compliance platforms that can keep FTZ data clean, auditable, and ready for AI. This article looks at 3...
NasdaqCM:PLBC
NasdaqCM:PLBCBanks

Plumas Bancorp (PLBC) Stock Faces Rising Non Performing Loans Despite Strong Net Interest Margin

Plumas Bancorp (PLBC) has reported Q2 2026 revenue of US$28.2 million and basic EPS of US$1.43, alongside trailing twelve month revenue of US$106.9 million and EPS of US$5.14 that build on the prior periods. Over the past few quarters, the company’s revenue has moved from US$19.7 million and EPS of US$1.07 in Q2 2025 to around US$22.9 million and US$1.58 in Q4 2025. It has now reached the latest Q2 2026 run rate, giving investors a clear progression in top line and per share earnings. With...
NasdaqGS:WABC
NasdaqGS:WABCBanks

Westamerica Bancorporation (WABC) Stock Faces Margin Compression Reinforcing Bearish Earnings Narratives

Westamerica Bancorporation (WABC) opened Q2 2026 with total revenue of US$62.8 million and basic EPS of US$1.16, while trailing 12 month figures show revenue of US$252.2 million and basic EPS of US$4.69 as the company continues to convert a meaningful share of its top line into net income. Over recent quarters, revenue has moved from US$66.9 million in Q1 2025 to US$62.8 million in Q2 2026, alongside quarterly basic EPS ranging between roughly US$1.12 and US$1.16. This context sets the stage...
NYSE:PNC
NYSE:PNCBanks

PNC (PNC) Stock Faces Narrative Test As Net Interest Margin Reaches 2.96% In Q2 2026

PNC Financial Services Group (PNC) just posted Q2 2026 results with total revenue of US$6.7 billion and basic EPS of US$4.85, alongside net income of US$2.0 billion. The update keeps the focus squarely on how the franchise is converting its loan book into earnings. Over the past few quarters, total revenue has ranged from US$5.2 billion in Q1 2025 to US$6.0 billion in Q1 2026, while quarterly EPS has moved between roughly US$3.52 and US$4.88. This gives investors a clearer view of how the...
NYSE:NKE
NYSE:NKELuxury

Nike (NKE) Stock Faces Margin Slippage As 6.7% Profitability Tests Bullish Narratives

Nike (NKE) has just wrapped up FY 2026 with fourth quarter revenue of US$10.97 billion and basic EPS of US$0.72, capping a trailing twelve month run of US$46.40 billion in revenue and basic EPS of US$2.10 as investors watch how these figures compare with the prior year. Over the past few quarters, revenue has ranged from US$10.97 billion to US$12.43 billion while quarterly basic EPS has moved between US$0.35 and US$0.72, giving investors a clear read on how the top line and EPS pattern has...
NYSE:PGR
NYSE:PGRInsurance

Progressive (PGR) Stock Faces Margin Narrative Test After Q2 2026 Profitability Holds Near 12.8%

Progressive (PGR) has just reported Q2 2026 results with total revenue of US$23.6 billion and basic EPS of US$5.68, alongside net income of US$3.3 billion, setting the tone for this earnings season update. Over recent quarters the company has seen revenue move from US$21.0 billion and EPS of US$4.38 in Q1 2025 to US$22.0 billion and EPS of US$4.81 in Q1 2026. Trailing twelve month EPS sits at US$19.98 on revenue of US$91.0 billion, giving investors a view of how current profitability links...
NasdaqGS:CTBI
NasdaqGS:CTBIBanks

Community Trust Bancorp (CTBI) Stock Faces Rising Non Performing Loans Despite Solid Q2 Margin

Community Trust Bancorp (CTBI) just posted Q2 2026 results with total revenue of US$75.7 million and basic EPS of US$1.64, while trailing twelve month revenue came in at US$287.0 million and EPS at US$5.99. The company has seen revenue move from US$253.8 million to US$287.0 million over the past year on a trailing basis, with EPS over the same period shifting from US$5.09 to US$5.99. With a trailing net profit margin of 37.6% and a reported net interest margin of 3.8% in the latest quarter,...
NYSE:STT
NYSE:STTCapital Markets

State Street (STT) Stock Faces Bullish EPS Narratives After Q2 2026 Profit Beat

State Street (STT) opened Q2 2026 with total revenue of US$4.0 billion and basic EPS of US$3.72, alongside net income of US$1.0 billion, putting fresh numbers behind its latest earnings release. The company has seen quarterly revenue move from US$3.3 billion in Q1 2025 to US$3.7 billion in Q1 2026 and then to US$4.0 billion in Q2 2026. Over the same period, basic EPS shifted from US$2.07 to US$2.53 and then to US$3.72, giving investors a clear view of how the top and bottom lines are tracking...
OTCPK:HARL
OTCPK:HARLBanks

Harleysville Financial (HARL) Stock Faces Q3 EPS Drop That Tests Bullish Profitability Narratives

Harleysville Financial (HARL) has laid out a clear snapshot of its recent performance, with Q3 2026 revenue at US$8.7 million and EPS at US$0.82, set against trailing 12 month revenue of US$34.5 million and EPS of US$3.43 that came alongside 41% earnings growth and a net profit margin of 35.7%. Over the last year, the company has seen revenue move from US$27.6 million to US$34.5 million and EPS lift from US$2.31 to US$3.43, giving investors a clearer view of how the current quarter fits into...
NasdaqGS:FFIN
NasdaqGS:FFINBanks

First Financial Bankshares (FFIN) Stock Net Interest Margin Supports Bullish Profitability Narrative In Q2 2026

First Financial Bankshares (FFIN) reported Q2 2026 revenue of US$168.6 million and basic EPS of US$0.50, supported by trailing twelve month revenue of US$637.2 million and EPS of US$1.88 that frame the latest quarter within a solid earnings run rate. Over recent periods, the company has seen quarterly revenue move from US$153.5 million in Q2 2025 to US$168.6 million in Q2 2026, while basic EPS over the same quarters went from US$0.47 to US$0.50, setting up this result as part of a steady...
NYSE:CNS
NYSE:CNSCapital Markets

Cohen & Steers (CNS) Stock Confronts Margin Slippage As EPS Rebounds In Q2 2026

Cohen & Steers (CNS) has just posted its Q2 2026 numbers, with total revenue of US$152.7 million and basic EPS of US$0.96, while trailing twelve month revenue sits at US$583.9 million and EPS at US$3.28. Over recent quarters, revenue has moved from US$134.5 million in Q1 2025 to US$145.6 million in Q1 2026 and then US$152.7 million in Q2 2026, with quarterly EPS ranging from US$0.68 in Q4 2025 to US$0.82 in Q1 2026 and US$0.96 in the latest quarter. This sets up a results season in which...
NasdaqGS:GSBC
NasdaqGS:GSBCBanks

Great Southern Bancorp (GSBC) Stock Faces Asset Quality Surprise As Non Performing Loans Drop Sharply

Great Southern Bancorp (GSBC) opened Q2 2026 with total revenue of US$56.9 million and basic EPS of US$1.45, alongside trailing twelve month revenue of US$226.8 million and EPS of about US$6.06 that frame the latest quarterly print. Over recent periods the company has seen revenue move from US$224.3 million to US$229.2 million and then to US$226.8 million on a trailing basis, while TTM EPS has shifted from roughly US$5.88 to US$6.23 and then to US$6.06. This gives investors a clear view of...
NasdaqGS:LULU
NasdaqGS:LULULuxury

Lululemon (LULU) Backs Syntetica And Opens Major North America Fulfillment Hub

Lululemon athletica (NasdaqGS:LULU) has invested in French nylon recycling startup Syntetica, aiming to integrate recycled materials into future product lines. The company has also opened a large automated distribution center in North America, focused on e-commerce fulfillment and regional logistics. Both moves reflect Lululemon's focus on supply chain sustainability and operational efficiency in its core athletic apparel business. Lululemon athletica has grown from a yoga-focused apparel...
NYSE:HOMB
NYSE:HOMBBanks

Home BancShares (HOMB) Stock Faces Rising Non‑Performing Loans Testing Bullish Growth Narratives

Home BancShares (HOMB) has reported Q2 2026 results with total revenue of US$289.9 million and basic EPS of US$0.59, alongside net income excluding extra items of US$119.3 million. Over the past year, the company has seen total revenue move from US$260.1 million in Q1 2025 to US$289.9 million in Q2 2026, while quarterly EPS has ranged from US$0.58 to roughly US$0.63. Trailing twelve month EPS now stands at about US$2.42. With a net interest margin at 4.51% and a cost to income ratio just...
NYSE:CWK
NYSE:CWKReal Estate

Cushman & Wakefield (CWK) Sees A Real Estate Turn In Apartments Industrial And Retail

Cushman & Wakefield (NYSE:CWK) has released new sector reports highlighting a turning point across several real estate segments. The company points to strengthening U.S. apartment and industrial markets, resilient U.S. retail vacancy trends, and rising contractor confidence in Asia Pacific offices. These updates reflect shifting fundamentals following recent market challenges across core property sectors. Cushman & Wakefield, trading at around $14.05, sits at the center of these changing...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Johnson & Johnson (JNJ) Stock Faces Margin Squeeze As Q2 Net Profitability Undercuts Bullish Narrative

Johnson & Johnson (JNJ) just posted Q2 2026 revenue of US$25.3 billion and basic EPS of US$2.27, with trailing 12 month EPS at US$8.70 and net income of US$21.0 billion framing the latest quarter against a much larger earnings base. Over recent quarters the company has seen revenue move from US$23.7 billion in Q2 2025 through a range of roughly US$24.0 billion to US$24.6 billion, while quarterly EPS has tracked between US$2.10 and US$2.30 outside of a one off spike in early 2025. This sets a...
NYSE:GEF
NYSE:GEFPackaging

Is Greif (GEF) Too Expensive After A 54% Five Year Return?

Greif stock has delivered a 54.1% return over the past 5 years, yet its current valuation screens as somewhat rich on market multiples and only middling on the broader checks. This raises the question of how much optimism is already in the price. A 54.1% 5 year return suggests Greif has rewarded patient shareholders, so investors now need to judge whether that strength is already reflected in the share price. Expectations around Greif's ability to sustain cash generation from its packaging...
NasdaqGM:GDS
NasdaqGM:GDSIT

GDS Holdings (GDS) Is Emerging As A Key AI Infrastructure Pick In China

GDS Holdings (NasdaqGM:GDS) is being highlighted as a key potential beneficiary of China's multi year national data center build out tied to accelerating AI adoption. The profile focuses on GDS's role within government backed digital infrastructure plans that prioritize high performance computing capacity for AI workloads. This policy driven push is presented as a material shift for data center operators positioned to support AI and cloud growth in China. GDS Holdings operates large scale...
NasdaqGS:MBX
NasdaqGS:MBXPharmaceuticals

Is MBX Biosciences (MBX) Fairly Valued As New Leadership Takes Charge?

Why this leadership shake up at MBX Biosciences matters for investors MBX Biosciences (MBX) is in focus after the board promoted Executive Chairman Steve Hoerter to Chief Executive Officer and Chairman, while confirming John Smither as Chief Financial Officer, reshaping the company’s senior leadership team. See our latest analysis for MBX Biosciences. The leadership changes at MBX Biosciences arrive after a sharp run up in momentum, with the stock showing a 45.47% 1 month share price return...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu (NasdaqGS:BIDU) Forms Apple AI Partnership And Pursues Hong Kong Listing

Baidu announces a reported AI partnership with Apple focused on integrating its generative AI capabilities. The company also confirms a voluntary move to a dual-primary listing on the Hong Kong Stock Exchange. Both developments come as Baidu's NasdaqGS:BIDU shares last closed at $112.82. Baidu is back in focus after it reported a new AI partnership with Apple and outlined plans to convert to a dual-primary listing in Hong Kong. The stock, NasdaqGS:BIDU, has fallen 24.9% year to date but is...
NasdaqGS:KLIC
NasdaqGS:KLICSemiconductor

AI Hardware Costs Are Rising and These US Equipment Stocks Stand Out

Stubborn import price pressure and talk of higher for longer rates are putting U.S. industrial and technology equipment stocks under a sharper spotlight, especially those tied to machinery, computers, and semiconductors. With Chinese import costs climbing and AI related hardware getting more expensive, some companies could see margins squeezed while others may find room to improve pricing power. This article explains how the latest data may affect a selection of large equipment manufacturers...
NYSE:ARI
NYSE:ARIMortgage REITs

Apollo Commercial Real Estate Finance (ARI) Is Down 31.3% After Dual S&P Index Removal Has The Bull Case Changed?

On 7 July 2026, Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) was removed from both the S&P TMI Index and the S&P Global BMI Index, reducing its presence in widely followed equity benchmarks. This dual index removal matters because it can alter how index-tracking funds and benchmark-aware investors engage with ARI, potentially affecting trading patterns and liquidity. Next, we’ll examine how ARI’s removal from key S&P indices might influence its existing investment narrative and...
NasdaqGM:TRVI
NasdaqGM:TRVIPharmaceuticals

Trevi Therapeutics (TRVI) Stock May Be Overvalued Despite Its 5 Year Surge

Trevi Therapeutics stock has delivered a very large 5 year return, yet the current valuation checks lean expensive rather than cheap, which raises the question of how much of that strength is already reflected in the price. Over the past 5 years, Trevi Therapeutics has returned about 7.6x, which sets a high bar for any further upside to be justified by fundamentals. Future progress in turning its drug pipeline into consistent revenue can support the current share price. The risk is that...